Herter & Co. advises Capiton portfolio company K.D. Pharma Group on rearrangement and expansion of financing structure
Herter & Co. has acted as Sole Debt Adviser on the rearrangement and expansion of debt facilities of K.D. Pharma Group, a portfolio company of funds advised by Capiton AG.
K.D. Pharma is one of the leading manufacturers of highly-purified omega-3 fatty acids for pharmaceutical and nutraceutical products, from which Capiton acquired a majority stake in 2013. Since then, K.D. Pharma has achieved significant growth of turnover and profit.
The solution includes a term loan to refinance existing debt, a capex facility for production expansion as well as a revolving credit facility and is fully underwritten by Deutsche Bank Direct Lending Europe.
“Herter & Co. supported us during the whole financing process, from the preparation, selection and approach of potential financing parties to the structuring of the financing package, the ultimate negotiations around the final agreement to the day of funding with a high level of expertise” said Igor van Santen, K.D. Pharma Group’s CFO.
The K.D. Pharma Group is the third largest Omega-3 producer in the world, employing 400 people and operating 7 sites located in the UK, Norway, Germany and the US. The company concentrates nutraceutical and pharmaceutical oils and makes customized finished products for its customers in soft gel capsule and bottled liquid forms. The K.D. Pharma Group has the global reach, technology and vertical integration necessary to develop customized Omega-3 products with complete supply chain efficiency for its customers.